Thermo Scientific™ B·R·A·H·M·S™ sFlt-1 KRYPTOR™

Catalog No.	Type
21-377-844	Immunofluorescent Assay
21-279-209	Calibrator
21-279-210	Controls

Catalog No. 21-377-844

Description

B·R·A·H·M·S provides a complete portfolio of biomarkers for the most reliable results in prenatal screening. Improve pre-eclampsia management from second to third trimester of pregnancy with B·R·A·H·M·S sFlt-1 KRYPTOR and B·R·A·H·M·S PlGF plus KRYPTOR and get results in less than 30 minutes.

B·R·A·H·M·S provides a complete portfolio of biomarkers for the management of pre-eclampsia throughout pregnancy. B·R·A·H·M·S sFlt-1 KRYPTOR together with B·R·A·H·M·S PlGF plus KRYPTOR is indicated as an aid for early prediction, diagnosis and prognosis of pre-eclampsia from week 20 and an identification of women at risk of developing term pre-eclampsia at week 36. Get confidence in your results with the high precision of B·R·A·H·M·S sFlt-1 KRYPTOR and get results in less than 30 minutes.

• The most complete intended uses for the management of pre-eclampsia in pregnancy with B·R·A·H·M·S sFlt-1 KRYPTOR
• Suitable for short-term prediction, diagnosis and prognosis of pre-eclampsia from week 20 of pregnancy with sFlt-1/PlGF ratio
• Suitable for screening for term pre-eclampsia at week 36 of pregnancy with PlGF
• Short incubation time with only 9 minutes for a short turnaround time
• Allows measurement in serum and plasma (EDTA)
• Large capacity with 75 tests
• Kit stable up to 29 days after opening onboard the instrument
• Easy workflow with only 2 calibrators and one calibration every 2 weeks
• Fits your throughput need with B·R·A·H·M·S KRYPTOR compact PLUS or B·R·A·H·M·S KRYPTOR GOLD
• Easy to use with sFlt-1/PlGF ratio calculated by the instrument

Specifications

• Content And Storage: Kit for 75 determinations, 2°C to 8°C
• Detectable Analytes: sFlt-1
• Detection Method: Immunofluorescence
• Sample Type: Serum, plasma (EDTA)
• Type: Immunofluorescent Assay
• For Use With (Application): For quantitative determination of soluble fms-like tyrosine kinase 1 (sFlt-1). Aid in diagnosis of pre-eclampsia, short-term prognosis of pre-eclampsia, risk assessment of developing pre-eclampsia in second and third trimester of pregnancy
• Includes: Kit for 75 determinations
• Analysis Time: 9 minutes
• Form: Ready-to-Use (RTU)

Thermo Fisher Scientific products are distributed globally and their uses, applications, indications, claims and availability of products in each country depend on local regulatory marketing authorization status, please consult the Instructions For Use (IFU) available in your country.